Lasagna's Law, US-based clinical research organisation,
Lasagna’s Law: Patient Recruitment and Clinical Trials Effective recruitment of patients is one of the most important ingredients for a successful clinical trial. Yet, today, 11% of clinical research sites fail to enroll even a single participant, and nearly 90% of clinical trials experience significant delays due to issues with patient recruitment. Over 40 years after Dr Louis Lasagna came up with his law of Read more
Clinical_Research_Focus_-_Edition_2nd
Clinical Research Focus. 2nd Edition Use of medical digital twins in clinical trials Unlearn and Merck KGaA have announced a new partnership using medical digital twins of patients in clinical trials. The collaboration aims to accelerate drug trials through the application of techniques using deep learning technology. It is claimed that it will allow researchers to reduce the size of control Read more
Celebrating women's contribution to clinical research
Celebrating women’s contribution to clinical research On this International Women’s Day, Cromos Pharma celebrates “Remarkable Women in Research”. Throughout history women have made pioneering contributions clinical research. Today we celebrate just some of these trailblazers. Click here to read our International Women’s Day 2022 publication. Cromos Pharma committed to gender equality At Cromos Pharma we are proud of the role women play within our company Read more
Clinical_Research_Focus_-_Edition_1st
Clinical Research Focus. 1st Edition First Genetically Modified Pig-To-Human Heart Transplant On January 7, 2022, surgeons from the University of Maryland School of Medicine (Baltimore, MD, USA) carried out the first pig-to-human heart transplant. The pioneering operation, led by Bartley Griffith, director of the cardiac transplant program at the university, involved the transplant of a genetically modified pig’s heart into Read more

Schedule a meeting

We are excited to connect with you, understand your goals, and explore how we can support your needs.

Contact us